Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001385290 | SCV001585093 | pathogenic | Hereditary hemochromatosis | 2023-04-06 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with TFR2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr136Leufs*80) in the TFR2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TFR2 are known to be pathogenic (PMID: 23600741, 26029709). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003473959 | SCV004203690 | likely pathogenic | Hemochromatosis type 3 | 2023-06-15 | criteria provided, single submitter | clinical testing |